ProCE Banner Activity

Preview of ASH 2016: Top Expert-Selected Studies

Conference Coverage
Clinical Thought
Look for these important studies at the coming Hematology meeting in San Diego. Be sure to also check our Web site frequently for downloadable PowerPoint slides featuring key presented data.

Released: December 01, 2016

Expiration: November 30, 2017

No longer available for credit.

Share

Faculty

John M. Burke

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

Jeffrey P. DONOTUSESharman

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Seagen

Faculty Disclosure

Primary Author

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

John M. Burke, MD, has disclosed that he has received consulting fees from Bayer, Celgene, Incyte, and Pfizer.

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

Jeff P. Sharman, MD, has disclosed that he has received consulting fees from AbbVie, Celgene, Genentech, Gilead, and Pharmacyclics, as well as contracted research from AbbVie, Acerta, Celgene, Genentech, Gilead, and Pharmacyclics.